Report Detail
Global Angiopoietin 2 Market Insights, Forecast to 2025
- RnM2932334 |
- 12 February, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
The global Angiopoietin 2 market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Angiopoietin 2 market based on company, product type, end user and key regions.
This report studies the global market size of Angiopoietin 2 in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Angiopoietin 2 in these regions.
This research report categorizes the global Angiopoietin 2 market by top players/brands, region, type and end user. This report also studies the global Angiopoietin 2 market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Amgen Inc.
AnGes MG, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
MedImmune, LLC
Regeneron Pharmaceuticals, Inc.
RXi Pharmaceuticals Corporation
Silence Therapeutics Plc
Synergys Biotherapeutics, Inc.
Market size by Product
Atu-111
BI-836880
LY-3127804
MEDI-3617
Others
Market size by End User
Hospital
Clinic
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Angiopoietin 2 market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Angiopoietin 2 market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Angiopoietin 2 companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Angiopoietin 2 submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Angiopoietin 2 are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Angiopoietin 2 market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Angiopoietin 2 Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Angiopoietin 2 Market Size Growth Rate by Product
- 1.4.2 Atu-111
- 1.4.3 BI-836880
- 1.4.4 LY-3127804
- 1.4.5 MEDI-3617
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Angiopoietin 2 Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Angiopoietin 2 Market Size
- 2.1.1 Global Angiopoietin 2 Revenue 2014-2025
- 2.1.2 Global Angiopoietin 2 Sales 2014-2025
- 2.2 Angiopoietin 2 Growth Rate by Regions
- 2.2.1 Global Angiopoietin 2 Sales by Regions
- 2.2.2 Global Angiopoietin 2 Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Angiopoietin 2 Sales by Manufacturers
- 3.1.1 Angiopoietin 2 Sales by Manufacturers
- 3.1.2 Angiopoietin 2 Sales Market Share by Manufacturers
- 3.1.3 Global Angiopoietin 2 Market Concentration Ratio (CR5 and HHI)
- 3.2 Angiopoietin 2 Revenue by Manufacturers
- 3.2.1 Angiopoietin 2 Revenue by Manufacturers (2014-2019)
- 3.2.2 Angiopoietin 2 Revenue Share by Manufacturers (2014-2019)
- 3.3 Angiopoietin 2 Price by Manufacturers
- 3.4 Angiopoietin 2 Manufacturing Base Distribution, Product Types
- 3.4.1 Angiopoietin 2 Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Angiopoietin 2 Product Type
- 3.4.3 Date of International Manufacturers Enter into Angiopoietin 2 Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Angiopoietin 2 Sales by Product
- 4.2 Global Angiopoietin 2 Revenue by Product
- 4.3 Angiopoietin 2 Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Angiopoietin 2 Breakdown Data by End User
6 North America
- 6.1 North America Angiopoietin 2 by Countries
- 6.1.1 North America Angiopoietin 2 Sales by Countries
- 6.1.2 North America Angiopoietin 2 Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Angiopoietin 2 by Product
- 6.3 North America Angiopoietin 2 by End User
7 Europe
- 7.1 Europe Angiopoietin 2 by Countries
- 7.1.1 Europe Angiopoietin 2 Sales by Countries
- 7.1.2 Europe Angiopoietin 2 Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Angiopoietin 2 by Product
- 7.3 Europe Angiopoietin 2 by End User
8 Asia Pacific
- 8.1 Asia Pacific Angiopoietin 2 by Countries
- 8.1.1 Asia Pacific Angiopoietin 2 Sales by Countries
- 8.1.2 Asia Pacific Angiopoietin 2 Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Angiopoietin 2 by Product
- 8.3 Asia Pacific Angiopoietin 2 by End User
9 Central & South America
- 9.1 Central & South America Angiopoietin 2 by Countries
- 9.1.1 Central & South America Angiopoietin 2 Sales by Countries
- 9.1.2 Central & South America Angiopoietin 2 Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Angiopoietin 2 by Product
- 9.3 Central & South America Angiopoietin 2 by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Angiopoietin 2 by Countries
- 10.1.1 Middle East and Africa Angiopoietin 2 Sales by Countries
- 10.1.2 Middle East and Africa Angiopoietin 2 Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Angiopoietin 2 by Product
- 10.3 Middle East and Africa Angiopoietin 2 by End User
11 Company Profiles
- 11.1 Amgen Inc.
- 11.1.1 Amgen Inc. Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Amgen Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Amgen Inc. Angiopoietin 2 Products Offered
- 11.1.5 Amgen Inc. Recent Development
- 11.2 AnGes MG, Inc.
- 11.2.1 AnGes MG, Inc. Company Details
- 11.2.2 Company Business Overview
- 11.2.3 AnGes MG, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 AnGes MG, Inc. Angiopoietin 2 Products Offered
- 11.2.5 AnGes MG, Inc. Recent Development
- 11.3 Boehringer Ingelheim GmbH
- 11.3.1 Boehringer Ingelheim GmbH Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Boehringer Ingelheim GmbH Angiopoietin 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Boehringer Ingelheim GmbH Angiopoietin 2 Products Offered
- 11.3.5 Boehringer Ingelheim GmbH Recent Development
- 11.4 Eli Lilly and Company
- 11.4.1 Eli Lilly and Company Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Eli Lilly and Company Angiopoietin 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Eli Lilly and Company Angiopoietin 2 Products Offered
- 11.4.5 Eli Lilly and Company Recent Development
- 11.5 F. Hoffmann-La Roche Ltd.
- 11.5.1 F. Hoffmann-La Roche Ltd. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Products Offered
- 11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
- 11.6 MedImmune, LLC
- 11.6.1 MedImmune, LLC Company Details
- 11.6.2 Company Business Overview
- 11.6.3 MedImmune, LLC Angiopoietin 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 MedImmune, LLC Angiopoietin 2 Products Offered
- 11.6.5 MedImmune, LLC Recent Development
- 11.7 Regeneron Pharmaceuticals, Inc.
- 11.7.1 Regeneron Pharmaceuticals, Inc. Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Products Offered
- 11.7.5 Regeneron Pharmaceuticals, Inc. Recent Development
- 11.8 RXi Pharmaceuticals Corporation
- 11.8.1 RXi Pharmaceuticals Corporation Company Details
- 11.8.2 Company Business Overview
- 11.8.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 RXi Pharmaceuticals Corporation Angiopoietin 2 Products Offered
- 11.8.5 RXi Pharmaceuticals Corporation Recent Development
- 11.9 Silence Therapeutics Plc
- 11.9.1 Silence Therapeutics Plc Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Silence Therapeutics Plc Angiopoietin 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Silence Therapeutics Plc Angiopoietin 2 Products Offered
- 11.9.5 Silence Therapeutics Plc Recent Development
- 11.10 Synergys Biotherapeutics, Inc.
- 11.10.1 Synergys Biotherapeutics, Inc. Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Synergys Biotherapeutics, Inc. Angiopoietin 2 Products Offered
- 11.10.5 Synergys Biotherapeutics, Inc. Recent Development
12 Future Forecast
- 12.1 Angiopoietin 2 Market Forecast by Regions
- 12.1.1 Global Angiopoietin 2 Sales Forecast by Regions 2019-2025
- 12.1.2 Global Angiopoietin 2 Revenue Forecast by Regions 2019-2025
- 12.2 Angiopoietin 2 Market Forecast by Product
- 12.2.1 Global Angiopoietin 2 Sales Forecast by Product 2019-2025
- 12.2.2 Global Angiopoietin 2 Revenue Forecast by Product 2019-2025
- 12.3 Angiopoietin 2 Market Forecast by End User
- 12.4 North America Angiopoietin 2 Forecast
- 12.5 Europe Angiopoietin 2 Forecast
- 12.6 Asia Pacific Angiopoietin 2 Forecast
- 12.7 Central & South America Angiopoietin 2 Forecast
- 12.8 Middle East and Africa Angiopoietin 2 Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Angiopoietin 2 Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Angiopoietin 2 . Industry analysis & Market Report on Angiopoietin 2 is a syndicated market report, published as Global Angiopoietin 2 Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Angiopoietin 2 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
